<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.450">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Cardiovascular autonomic dysfunction impact on cardiovascular complications across glucose metabolism - 4&nbsp; Background</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./3-aim_hypothesis.html" rel="next">
<link href="./1-introduction.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>


</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
      <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./2-background.html"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Background</span></a></li></ol></nav>
      <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
      </a>
      <button type="button" class="btn quarto-search-button" aria-label="" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Cardiovascular autonomic dysfunction impact on cardiovascular complications across glucose metabolism</a> 
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">This section will not be numbered</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./pdf1-supervisors.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Supervisors and assessment committee</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-disclosure.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Financial support{.unnumbered}</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-preface.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Preface</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./acknowledgements.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Acknowledgements</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-papers.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Papers in the dissertation</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./blank-page.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">{.unnumbered}</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-abbreviations.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Abbreviations</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./1-introduction.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Introduction</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./2-background.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Background</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./3-aim_hypothesis.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Aim and hypothesis</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./4-methods.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Materials and methods</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./5-results.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Results</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./6-discussion.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Discussion</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./7-perspectives.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Perspective</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./8-conclusion.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Conclusion</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-abstract.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Summary</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
 <span class="menu-text">Appendices</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./app1-resources.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">A</span>&nbsp; <span class="chapter-title">Appendix</span></span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#type-2-diabetes-and-prediabetes" id="toc-type-2-diabetes-and-prediabetes" class="nav-link active" data-scroll-target="#type-2-diabetes-and-prediabetes"><span class="header-section-number">4.1</span> Type 2 diabetes and prediabetes</a></li>
  <li><a href="#cardiovascular-disease" id="toc-cardiovascular-disease" class="nav-link" data-scroll-target="#cardiovascular-disease"><span class="header-section-number">4.2</span> Cardiovascular disease</a>
  <ul class="collapse">
  <li><a href="#arteriosclerosis" id="toc-arteriosclerosis" class="nav-link" data-scroll-target="#arteriosclerosis"><span class="header-section-number">4.2.1</span> Arteriosclerosis</a></li>
  <li><a href="#atherosclerosis" id="toc-atherosclerosis" class="nav-link" data-scroll-target="#atherosclerosis"><span class="header-section-number">4.2.2</span> Atherosclerosis</a></li>
  <li><a href="#heart-failure" id="toc-heart-failure" class="nav-link" data-scroll-target="#heart-failure"><span class="header-section-number">4.2.3</span> Heart failure</a></li>
  </ul></li>
  <li><a href="#cardiovascular-autonomic-dysfunction" id="toc-cardiovascular-autonomic-dysfunction" class="nav-link" data-scroll-target="#cardiovascular-autonomic-dysfunction"><span class="header-section-number">4.3</span> Cardiovascular autonomic dysfunction</a></li>
  <li><a href="#risk-stratification" id="toc-risk-stratification" class="nav-link" data-scroll-target="#risk-stratification"><span class="header-section-number">4.4</span> Risk-stratification</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Background</span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<p>This background introduces the concept of type 2 diabetes (T2D) and its associated cardiovascular risk. An overview is then provided of various cardiovascular complications, including arteriosclerosis, atherosclerosis, and heart failure. Finally, cardiovascular autonomic function (autonomic function) is described, along with its potential to enhance our understanding of cardiovascular disease (CVD).</p>
<section id="type-2-diabetes-and-prediabetes" class="level2" data-number="4.1">
<h2 data-number="4.1" class="anchored" data-anchor-id="type-2-diabetes-and-prediabetes"><span class="header-section-number">4.1</span> Type 2 diabetes and prediabetes</h2>
<p>The progression from normal glucose metabolism (NGM) to T2D is characterized by sustained elevations in blood glucose levels. T2D is defined by a progressive decline in beta-cell function, most often as a consequence of chronic insulin resistance.<span class="citation" data-cites="tabák2012 bonora2018"><sup><a href="references.html#ref-tabák2012" role="doc-biblioref">1</a>,<a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Insulin resistance occurs when tissues such as muscle and liver lose their sensitivity to insulin.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> As a result, glucose is not effectively taken up by these tissues and remains in circulation.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Meanwhile, beta-cell function deteriorates, leading to a diminished insulin response to glucose levels.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Years before a T2D diagnosis, these changes contribute to rising fasting and postprandial glucose levels.<span class="citation" data-cites="tabák2012"><sup><a href="references.html#ref-tabák2012" role="doc-biblioref">1</a></sup></span></p>
<p>The body regulates glucose through various mechanism. During fasting, pancreatic alpha cells secrete glucagon, which stimulates hepatic glucose production via glycogenolysis and gluconeogenesis.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> After a meal, rising blood glucose levels stimulate pancreatic beta cells to release insulin and trigger the secretion of incretins, such as glucagon-like peptide-1 (GLP-1) from the intestines.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Insulin and incretins work together to suppress hepatic glucose production, while insulin promotes glucose uptake in muscle and adipose tissue.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Excess glucose is primarily stored as glycogen in the liver and muscles, with some converted to triglycerides for long-term storage. Multiple organs, including the pancreas, liver, kidneys, intestines, muscle, and adipose tissue are involved in this coordinated process.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> The autonomic nervous system plays a supportive role in glucose homeostasis by modulating metabolic activity. Parasympathetic signals tend to reduce glucose production, while sympathetic signals enhance it, especially during hypoglycemia.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span></p>
<p>The World Health Organization (WHO) and American Diabetes Association (ADA) diagnostic criteria for T2D include fasting plasma glucose ≥7.0 mmol/L, 2 hour plasma glucose ≥11.1 mmol/L during an oral glucose tolerance test (OGTT), or hemoglobin A1c (HbA1c) ≥6.5 percent (48 mmol/mol).<span class="citation" data-cites="worldhealthorganization2020 americandiabetesassociationprofessionalpracticecommittee2021"><sup><a href="references.html#ref-worldhealthorganization2020" role="doc-biblioref">3</a>,<a href="references.html#ref-americandiabetesassociationprofessionalpracticecommittee2021" role="doc-biblioref">4</a></sup></span> The OGTT measures glucose levels two hours after the ingestion of a standard 75 gram glucose load in the fasting state.<span class="citation" data-cites="americandiabetesassociationprofessionalpracticecommittee2021"><sup><a href="references.html#ref-americandiabetesassociationprofessionalpracticecommittee2021" role="doc-biblioref">4</a></sup></span> Progression towards diabetes is a continuous process, with type 2 diabetes defined based on glucose thresholds associated with an increased risk of diabetes specific microvascular complications, particularly retinopathy.<span class="citation" data-cites="colagiuri2010"><sup><a href="references.html#ref-colagiuri2010" role="doc-biblioref">5</a></sup></span> Many complications of diabetes, such as macrovascular disease, neuropathy, cancer, and cognitive impairment, may begin to develop at earlier stages of dysglycemia.<span class="citation" data-cites="mokhtar2023 huang2014 stehouwer2018"><sup><a href="references.html#ref-mokhtar2023" role="doc-biblioref">6</a>–<a href="references.html#ref-stehouwer2018" role="doc-biblioref">8</a></sup></span> This stage is referred to as prediabetes or high risk of diabetes and is defined by fasting plasma glucose levels between 6.1 and 6.9 mmol/L, 2 hour plasma glucose levels between 7.8 and 11.0 mmol/L (WHO criteria), and HbA1c levels between 5.7 and 6.4 percent (39 to 47 mmol/mol) (ADA criteria).<span class="citation" data-cites="americandiabetesassociationprofessionalpracticecommittee2021"><sup><a href="references.html#ref-americandiabetesassociationprofessionalpracticecommittee2021" role="doc-biblioref">4</a></sup></span> In parallel with the growing prevalence of T2D, the prevalence of prediabetes is also increasing.<span class="citation" data-cites="rooney2023"><sup><a href="references.html#ref-rooney2023" role="doc-biblioref">9</a></sup></span></p>
<p>Risk factors for progression to T2D and its complications range from genetic predisposition to lifestyle and socioenvironmental factors. While the most common risk factor for diabetes is central obesity, various other risk factors such as low density lipoprotein (LDL) cholesterol, triglycerides, and systolic blood pressure tend to cluster with obesity and with each other.<span class="citation" data-cites="færch2013"><sup><a href="references.html#ref-færch2013" role="doc-biblioref">10</a></sup></span> Many of the risk factors for diabetes are also shown to be risk factors for CVD and other diabetes complications.<span class="citation" data-cites="færch2013"><sup><a href="references.html#ref-færch2013" role="doc-biblioref">10</a></sup></span></p>
<p>Diabetes increases the risk of both microvascular and macrovascular complications, which are major contributors to the morbidity and mortality associated with the disease.<span class="citation" data-cites="bonora2018"><sup><a href="references.html#ref-bonora2018" role="doc-biblioref">2</a></sup></span> Beyond conventional CVD risk factors, chronic hyperglycemia promotes the formation of harmful byproducts such as reactive oxygen species and advanced glycation end products, which drive oxidative stress and inflammation.<span class="citation" data-cites="ritchie2020"><sup><a href="references.html#ref-ritchie2020" role="doc-biblioref">11</a></sup></span> These processes contribute to endothelial dysfunction and vascular damage.<span class="citation" data-cites="ritchie2020"><sup><a href="references.html#ref-ritchie2020" role="doc-biblioref">11</a></sup></span> While the general mechanisms underlying macrovascular complications are well described, the identification of preclinical stages of CVD and the differentiation of CVD risk between individuals at high risk of diabetes and those with established T2D require further clarification.<span class="citation" data-cites="birkenfeld2024"><sup><a href="references.html#ref-birkenfeld2024" role="doc-biblioref">12</a></sup></span></p>
</section>
<section id="cardiovascular-disease" class="level2" data-number="4.2">
<h2 data-number="4.2" class="anchored" data-anchor-id="cardiovascular-disease"><span class="header-section-number">4.2</span> Cardiovascular disease</h2>
<p>Globally, CVD remains the leading cause of death. At the population level, CVD risk is primarily attributable to modifiable lifestyle behaviors such as chronic stress, physical inactivity, unhealthy diet, excessive alcohol consumption, and smoking, as well as socio-environmental factors like socio-economic status and air pollution.<span class="citation" data-cites="yusuf2020"><sup><a href="references.html#ref-yusuf2020" role="doc-biblioref">13</a></sup></span> At the individual level, these exposures often manifest through more proximal biological risk factors, including hypertension, hypercholesterolemia, diabetes, and obesity.<span class="citation" data-cites="wood2001"><sup><a href="references.html#ref-wood2001" role="doc-biblioref">14</a></sup></span> Along the causal pathway, these intermediate conditions tend to cluster, thereby accelerating disease progression. These processes are underpinned by biomolecular mechanisms, including local and systemic inflammation, oxidative stress involving oxidized low-density lipoprotein (LDL), and dysregulated immune responses mediated by pro-inflammatory cytokines and signaling pathways.<span class="citation" data-cites="moore2019"><sup><a href="references.html#ref-moore2019" role="doc-biblioref">15</a></sup></span> Risk factors contribute to distinct pathophysiological mechanisms across different types of CVD, involving structural, signaling, inflammatory, and hemodynamic changes within the cardiovascular system.<span class="citation" data-cites="fuchs2020 moore2019 mitchell2020"><sup><a href="references.html#ref-moore2019" role="doc-biblioref">15</a>–<a href="references.html#ref-mitchell2020" role="doc-biblioref">17</a></sup></span> Among these, cellular and molecular signaling pathways play a central role in regulating vascular tone, cardiac function, and inflammatory responses. These processes are closely modulated by the autonomic nervous system through sympathetic and parasympathetic nerve branches.<span class="citation" data-cites="florea2014 mancia2014 ziegler2025 wagner2023"><sup><a href="references.html#ref-florea2014" role="doc-biblioref">18</a>–<a href="references.html#ref-wagner2023" role="doc-biblioref">21</a></sup></span></p>
<section id="arteriosclerosis" class="level3" data-number="4.2.1">
<h3 data-number="4.2.1" class="anchored" data-anchor-id="arteriosclerosis"><span class="header-section-number">4.2.1</span> Arteriosclerosis</h3>
<p>Evidence emphasizes the role of vascular aging in early disease development, extending beyond the traditional focus on cardiovascular endpoints.<span class="citation" data-cites="mitchell2020"><sup><a href="references.html#ref-mitchell2020" role="doc-biblioref">17</a></sup></span> Arteriosclerosis, commonly referred to as arterial stiffness, has been identified as a hallmark of this process. Biologically, the medial layer of large arteries consists of a structured network of vascular smooth muscle cells together with elastic and collagen fibers, forming functional musculoelastic sheets.<span class="citation" data-cites="lee2010"><sup><a href="references.html#ref-lee2010" role="doc-biblioref">22</a></sup></span> Arterial stiffness has been found to arise from progressive remodeling of the arterial wall.<span class="citation" data-cites="mitchell2020 lu2023"><sup><a href="references.html#ref-mitchell2020" role="doc-biblioref">17</a>,<a href="references.html#ref-lu2023" role="doc-biblioref">23</a></sup></span> This remodeling has been driven by changes in the structural interactions between elastin and collagen fibers, along with functional alterations in vascular smooth muscle cells and the accumulation of calcium and advanced glycation end products.<span class="citation" data-cites="lee2010"><sup><a href="references.html#ref-lee2010" role="doc-biblioref">22</a></sup></span> Remodeling of the arterial wall has been shown to increase systolic blood pressure and reduce coronary perfusion, thereby contributing to the development of hypertension and, eventually, cardiovascular disease.<span class="citation" data-cites="zhong2018"><sup><a href="references.html#ref-zhong2018" role="doc-biblioref">24</a></sup></span> Additionally, arterial stiffness has been associated with elevated pulsatile load on the microcirculation, promoting the progression of chronic kidney disease, vascular dementia, and Alzheimer’s disease.<span class="citation" data-cites="mitchell2020"><sup><a href="references.html#ref-mitchell2020" role="doc-biblioref">17</a></sup></span></p>
</section>
<section id="atherosclerosis" class="level3" data-number="4.2.2">
<h3 data-number="4.2.2" class="anchored" data-anchor-id="atherosclerosis"><span class="header-section-number">4.2.2</span> Atherosclerosis</h3>
<p>Atherosclerosis is characterized by the accumulation of cholesterol, lipids, and other substances within the arterial walls, forming plaques that narrow the arteries and reduce blood flow often at specific sites such as the coronary and carotid arteries.<span class="citation" data-cites="libby2021"><sup><a href="references.html#ref-libby2021" role="doc-biblioref">25</a></sup></span> This chronic process can lead to progressive occlusion of the vessel, contributing to reduced oxygen supply to the heart<span class="citation" data-cites="zaman"><sup><a href="references.html#ref-zaman" role="doc-biblioref">26</a></sup></span>, often leading to symptoms of angina.</p>
<p>Atherosclerotic plaques can be classified into stable and unstable types, each with distinct structural characteristics and clinical implications. Stable plaques typically have a thick fibrous cap composed of collagen, a small lipid core, and low levels of inflammation.<span class="citation" data-cites="kawai2024"><sup><a href="references.html#ref-kawai2024" role="doc-biblioref">27</a></sup></span> These plaques are less likely to rupture and tend to remain intact over time due to internal remodeling. In contrast, unstable plaques, also known as vulnerable plaques, often contain a large lipid-rich necrotic core, a thin fibrous cap, and infiltration by inflammatory cells such as macrophages.<span class="citation" data-cites="kawai2024"><sup><a href="references.html#ref-kawai2024" role="doc-biblioref">27</a></sup></span> A well-recognized subtype of unstable plaque is the thin-cap fibroatheroma, which is particularly prone to rupture. When rupture occurs, the necrotic core becomes exposed to the bloodstream, initiating the formation of a thrombus or blood clot. This acute event can abruptly obstruct the artery, resulting in myocardial infarction (MI).<span class="citation" data-cites="kawai2024"><sup><a href="references.html#ref-kawai2024" role="doc-biblioref">27</a></sup></span> Chronic ischemia due to reduced coronary perfusion can lead to myocardial remodeling, impaired contractility, and electrical instability, thereby increasing the risk of arrhythmias and heart failure.<span class="citation" data-cites="alasady2013 elgendy2019"><sup><a href="references.html#ref-alasady2013" role="doc-biblioref">28</a>,<a href="references.html#ref-elgendy2019" role="doc-biblioref">29</a></sup></span></p>
<p><strong>Myocardial infarction</strong></p>
<p>MI occurs due to the rupture of an atherosclerotic plaque in the coronary arteries, triggering thrombus formation that blocks blood flow.<span class="citation" data-cites="thygesen2018"><sup><a href="references.html#ref-thygesen2018" role="doc-biblioref">30</a></sup></span> This leads to oxygen deprivation (ischemia) and subsequent myocardial injury or necrosis.<span class="citation" data-cites="thygesen2018"><sup><a href="references.html#ref-thygesen2018" role="doc-biblioref">30</a></sup></span> If untreated, this process can cause extensive cardiac damage and fatal arrhythmias.<span class="citation" data-cites="thygesen2018"><sup><a href="references.html#ref-thygesen2018" role="doc-biblioref">30</a></sup></span> Over the past decades, the incidence of MI has declined in high-income countries with a marked reduction in MI-related mortality.<span class="citation" data-cites="cherla2024"><sup><a href="references.html#ref-cherla2024" role="doc-biblioref">31</a></sup></span> These improvements are largely attributed to a combination of public health initiatives and medical advances. On the public health front, a substantial decrease in smoking prevalence has been the most important lifestyle-related factor contributing to the reduction in CVD.<span class="citation" data-cites="bilano2015 ockene1997"><sup><a href="references.html#ref-bilano2015" role="doc-biblioref">32</a>,<a href="references.html#ref-ockene1997" role="doc-biblioref">33</a></sup></span> Medically, the improved preventive management of hypertension and hyperlipidemia has reduced the burden of atherosclerotic disease.<span class="citation" data-cites="cherla2024"><sup><a href="references.html#ref-cherla2024" role="doc-biblioref">31</a></sup></span> In acute care, the widespread adoption of evidence-based interventions such as thrombolytic therapy, percutaneous coronary interventions (including stenting), and coronary artery bypass grafting has improved survival and outcomes following MI.<span class="citation" data-cites="wallentin2014"><sup><a href="references.html#ref-wallentin2014" role="doc-biblioref">34</a></sup></span> In T2D, the risk of MI is elevated by 72%, with an approximately threefold risk among patients under 60 years compared to age under 60 without T2D.<span class="citation" data-cites="shah2015"><sup><a href="references.html#ref-shah2015" role="doc-biblioref">35</a></sup></span> Similar to the general population, MI incidence and fatality have declined among individuals with diabetes.<span class="citation" data-cites="glynn2024 greggedwardw.a"><sup><a href="references.html#ref-glynn2024" role="doc-biblioref">36</a>,<a href="references.html#ref-greggedwardw.a" role="doc-biblioref">37</a></sup></span></p>
<p><strong>Stroke</strong></p>
<p>The majority of strokes are ischemic and result from an obstruction in a cerebral artery. The process often begins with the development of atherosclerotic plaques at the carotid artery bifurcation, which can lead to the formation of emboli<span class="citation" data-cites="campbell2019"><sup><a href="references.html#ref-campbell2019" role="doc-biblioref">38</a></sup></span>. These emboli may travel through the bloodstream and become lodged in the cerebral arterial tree, ultimately causing an ischemic stroke<span class="citation" data-cites="campbell2019"><sup><a href="references.html#ref-campbell2019" role="doc-biblioref">38</a></sup></span>. The second main cause is hemorrhagic stroke, which is characterized as a hypertensive small-vessel disease, leading to small lipohyalinotic aneurysms that subsequently rupture, causing intracerebral bleeding.<span class="citation" data-cites="magid-bernstein2022 donnan2008"><sup><a href="references.html#ref-magid-bernstein2022" role="doc-biblioref">39</a>,<a href="references.html#ref-donnan2008" role="doc-biblioref">40</a></sup></span> Ischemic stroke remains one of the global leading contributors to mortality and disability.<span class="citation" data-cites="vos2020"><sup><a href="references.html#ref-vos2020" role="doc-biblioref">41</a></sup></span> The incidence, prevalence, and cause-specific mortality of stroke remain high but have stagnated, although some declines have been observed in high-income countries.<span class="citation" data-cites="li2024"><sup><a href="references.html#ref-li2024" role="doc-biblioref">42</a></sup></span> Individuals with elevated glucose levels, as measured by fasting plasma glucose, OGTT, or HbA1c, have a 26% higher risk of stroke compared to those with normal glucose levels.<span class="citation" data-cites="lee2012 barr2007"><sup><a href="references.html#ref-lee2012" role="doc-biblioref">43</a>,<a href="references.html#ref-barr2007" role="doc-biblioref">44</a></sup></span> In T2D, the ischemic stroke risk is elevated almost two-fold compared with individuals without diabetes.<span class="citation" data-cites="shah2015"><sup><a href="references.html#ref-shah2015" role="doc-biblioref">35</a></sup></span></p>
</section>
<section id="heart-failure" class="level3" data-number="4.2.3">
<h3 data-number="4.2.3" class="anchored" data-anchor-id="heart-failure"><span class="header-section-number">4.2.3</span> Heart failure</h3>
<p>Heart failure develops gradually with age and often accelerates with the progression of T2D. As prevention and treatment of CVD have improved survival in recent years, the prevalence of heart failure has increased, while the incidence remains stable, but may rise with aging populations.<span class="citation" data-cites="khan2024"><sup><a href="references.html#ref-khan2024" role="doc-biblioref">45</a></sup></span></p>
<p>Heart failure may arise as a consequence of atherosclerosis, arteriosclerosis, or both, contributing to myocardial ischemia, pressure overload, and structural cardiac changes.<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> Heart failure can be defined hemodynamically as the inability to maintain adequate cardiac output at rest or during exertion, or the ability to do so only with elevated cardiac filling pressures.<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> It is a complex cardiovascular disease caused by structural and functional changes in the heart musculature, affecting systolic and/or diastolic pumping function.<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> Heart failure is generally classified into two subtypes: heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> Both subtypes involve cardiac remodeling but are defined by left ventricular ejection fraction (LVEF).<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> HFrEF is defined by an LVEF &lt; 40%, while HFpEF is characterized by an LVEF ≥ 50% along with structural or functional cardiac abnormalities, as assessed by echocardiography.<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">46</a></sup></span> HFrEF is often a consequence of repeated, non-fatal MIs. These events can leave behind scar tissue in the myocardium, impairing the heart’s ability to contract effectively and leading to progressive systolic dysfunction.<span class="citation" data-cites="campbell2024"><sup><a href="references.html#ref-campbell2024" role="doc-biblioref">47</a></sup></span></p>
<p>The most common feature of HFpEF is left ventricular diastolic dysfunction, caused by impaired relaxation and increased stiffness, leading to elevated left atrial pressure and reduced diastolic reserve.<span class="citation" data-cites="normand2019 pop-busui2022"><sup><a href="references.html#ref-normand2019" role="doc-biblioref">48</a>,<a href="references.html#ref-pop-busui2022" role="doc-biblioref">49</a></sup></span> Over the past decades, the prevalence of HFpEF has increased with an aging population and more individuals living with conditions such as hypertension, diabetes, and obesity.<span class="citation" data-cites="campbell2024"><sup><a href="references.html#ref-campbell2024" role="doc-biblioref">47</a></sup></span> It is diagnosed based on structural or functional abnormalities identified through echocardiographic measures, such as left ventricular hypertrophy, left atrial enlargement, or elevated filling pressures.<span class="citation" data-cites="campbell2024"><sup><a href="references.html#ref-campbell2024" role="doc-biblioref">47</a></sup></span> The diagnosis may seem straightforward, but it is often challenging in community settings, as patients frequently present without typical heart failure symptoms (e.g., shortness of breath) and are not routinely assessed with biomarkers like N-terminal pro-B-type natriuretic peptide (NT-proBNP) or brain-neuretic-peptide (BNP).<span class="citation" data-cites="pop-busui2022 campbell2024"><sup><a href="references.html#ref-campbell2024" role="doc-biblioref">47</a>,<a href="references.html#ref-pop-busui2022" role="doc-biblioref">49</a></sup></span> As a result, HFpEF is commonly underdiagnosed and consequently detected at more severe stages, leading to hospitalization.<span class="citation" data-cites="campbell2024 pop-busui2022"><sup><a href="references.html#ref-campbell2024" role="doc-biblioref">47</a>,<a href="references.html#ref-pop-busui2022" role="doc-biblioref">49</a></sup></span></p>
</section>
</section>
<section id="cardiovascular-autonomic-dysfunction" class="level2" data-number="4.3">
<h2 data-number="4.3" class="anchored" data-anchor-id="cardiovascular-autonomic-dysfunction"><span class="header-section-number">4.3</span> Cardiovascular autonomic dysfunction</h2>
<p>The cardiovascular system is regulated by the autonomic nervous system, which influences heart rate and vasoconstrictuion through the sympathetic and parasympathetic nerves.<span class="citation" data-cites="ziegler2025"><sup><a href="references.html#ref-ziegler2025" role="doc-biblioref">20</a></sup></span> Sympathetic activation increases heart rate and myocardial contractility by stimulating the sinoatrial (SA) node, atrioventricular (AV) node, and ventricular myocardium. In contrast, parasympathetic activation primarily reduces heart rate by directly modulating SA node activity through vagal stimulation.<span class="citation" data-cites="ziegler2025"><sup><a href="references.html#ref-ziegler2025" role="doc-biblioref">20</a></sup></span> It also slows AV nodal conduction, predominantly via the left vagus nerve, thereby prolonging atrioventricular conduction time.<span class="citation" data-cites="ziegler2025"><sup><a href="references.html#ref-ziegler2025" role="doc-biblioref">20</a></sup></span> Afferently nerves mainly carry sensory information (e.g., baroreceptor input from the carotid sinus and aortic arch) to the brain, which then adjusts efferent autonomic output to regulate arterial tone. Hence, the autonomic nervous system dynamically regulates heart rate and blood pressure to maintain homoeostasis in response to physiological demands, such as rest, stress, eating and physical activity.<span class="citation" data-cites="ziegler2025"><sup><a href="references.html#ref-ziegler2025" role="doc-biblioref">20</a></sup></span></p>
<div class="quarto-layout-panel" data-fig-cap="**Autonomic nervous system and heart rate variability. . **">
<div class="quarto-layout-row quarto-layout-valign-top">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<p><img src="images/hrv_ans.png" class="img-fluid" data-fig-align="right"> <em>(Source: Author)</em></p>
</div>
</div>
</div>
<p>In youth, the autonomic nervous system is highly adaptive and responsive to living conditions, maintaining autonomic balance. However, with aging, there is a gradual decline in parasympathetic function and an increase in sympathetic activity. Additionally, metabolism-related conditions such as obesity and diabetes have been shown to further contribute to cardiovascular autonomic dysfunction (autonomic dysfunction).<span class="citation" data-cites="schlaich2015"><sup><a href="references.html#ref-schlaich2015" role="doc-biblioref">50</a></sup></span> Autonomic dysfunction reflects a stressed cardiometabolic environment, as both dysfunction in lipid and glucose metabolism are associated with increased sympathetic activity.<span class="citation" data-cites="schlaich2015"><sup><a href="references.html#ref-schlaich2015" role="doc-biblioref">50</a></sup></span> This dysfunction may result from cumulative neural damage mediated by mechanisms such as hyperinsulinemia, insulin resistance, and elevated levels of adipokines. At the same time, autonomic dysfunction is known to disrupt lipid and glucose metabolism.<span class="citation" data-cites="schlaich2015"><sup><a href="references.html#ref-schlaich2015" role="doc-biblioref">50</a></sup></span> Therefore, the relationship between autonomic dysfunction and cardiometabolic factors is likely a vicious cycle.<span class="citation" data-cites="rinaldi2023"><sup><a href="references.html#ref-rinaldi2023" role="doc-biblioref">51</a></sup></span> The consequences can lead to autonomic dysfunction/neuropathy (CAN), resulting in dysregulation in heart rate and vascular dynamics. CAN prevalent in 12-73% in indiviudals with T2D is liked to CVD diabetic kidney disease, and all-cause mortality.<span class="citation" data-cites="eleftheriadou2024 mahinchowdhury2021 tang2023"><sup><a href="references.html#ref-eleftheriadou2024" role="doc-biblioref">52</a>–<a href="references.html#ref-tang2023" role="doc-biblioref">54</a></sup></span> In this dissertation, ‘autonomic dysfunction’ will be used as the broader term, while ‘CAN’ will refer specifically to autonomic dysfunction resulting from neuropathy in diabetes.</p>
<p>Autonomic function can be assessed using heart rate variability (HRV) indices, which measure the variation in successive normal RR intervals in milliseconds. HRV provides time- and frequency-domain estimates of the balance between sympathetic and parasympathetic activity.<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">55</a></sup></span> High HRV reflects an autonomic nervous system with strong adaptability to the body’s demands, whereas low variation indicates poor adaptation to changing conditions. HRV changes in response to different physiological or environmental conditions (e.g., sleep, stress, posture, physical activity), and these changes can be observed in its natural 24-hour (circadian) pattern.<span class="citation" data-cites="natarajan2020"><sup><a href="references.html#ref-natarajan2020" role="doc-biblioref">56</a></sup></span> Most studies have examined autonomic function using short-term ECG recordings at rest.<span class="citation" data-cites="hillebrand2013"><sup><a href="references.html#ref-hillebrand2013" role="doc-biblioref">57</a></sup></span> However, extended HRV recordings across the circadian cycle may offer deeper insights into the influence of lower-frequency variability sources, such as very-low frequency (0.003–0.04 Hz) and ultra-low frequency (≤0.003 Hz).<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">55</a></sup></span> HRV has been applied across several research domains. For example, in psychology as a marker of mental stress, in exercise physiology as an indicator of recovery, in cardiovascular research as a marker of autonomic dysfunction due to cardiac complications, and in diabetes research as a marker of autonomic neuropathy.<span class="citation" data-cites="immanuel2023 dong2016 singh1996 eleftheriadou2024"><sup><a href="references.html#ref-eleftheriadou2024" role="doc-biblioref">52</a>,<a href="references.html#ref-immanuel2023" role="doc-biblioref">58</a>–<a href="references.html#ref-singh1996" role="doc-biblioref">60</a></sup></span>T2D alters the expression of sympathetic bursts, as measured by resting muscle sympathetic nerve activity (MSNA). MSNA is elevated in individuals with both T2D and hypertension, compared to those who are normotensive, regardless of whether they have diabetes or not.<span class="citation" data-cites="huggett2003"><sup><a href="references.html#ref-huggett2003" role="doc-biblioref">61</a></sup></span> Parasympathetic activity is also impaired in individuals with high cardiometabolic risk and T2D, as reflected by reduced baroreflex sensitivity and lower HF and RMSSD short-term HRV.<span class="citation" data-cites="cseh2020"><sup><a href="references.html#ref-cseh2020" role="doc-biblioref">62</a></sup></span> Before onset of diabetes and during progression of diabetes long-term (24-hour) HRV has shown to be lower compare to those with .<span class="citation" data-cites="rinaldi2023 coopmans2020"><sup><a href="references.html#ref-rinaldi2023" role="doc-biblioref">51</a>,<a href="references.html#ref-coopmans2020" role="doc-biblioref">63</a></sup></span> Cardiovascular autonomic reflex tests (CARTs) and orthostatic hypotension are considered the gold standard for assessing CAN.<span class="citation" data-cites="hansen2025"><sup><a href="references.html#ref-hansen2025" role="doc-biblioref">64</a></sup></span> The diagnosis includes assessing pulse rate ratio under test conditions, such as the deep breathing test, the lying-to-standing test, and the Valsalva maneuver.<span class="citation" data-cites="hansen2025"><sup><a href="references.html#ref-hansen2025" role="doc-biblioref">64</a></sup></span> Both HRV and CARTs have shown to be associated with cardiovascular disease, heart failure, and all-cause mortality, primarily in populations with T2D or established cardiovascular disease.<span class="citation" data-cites="hillebrand2013 mahinchowdhury2021 davis2024"><sup><a href="references.html#ref-mahinchowdhury2021" role="doc-biblioref">53</a>,<a href="references.html#ref-hillebrand2013" role="doc-biblioref">57</a>,<a href="references.html#ref-davis2024" role="doc-biblioref">65</a></sup></span> However, it remains unclear at which stage in the progression of diabetes risk to pre-diabetes to diabetes these measures begin to influence the risk of cardiovascular complications.</p>
</section>
<section id="risk-stratification" class="level2" data-number="4.4">
<h2 data-number="4.4" class="anchored" data-anchor-id="risk-stratification"><span class="header-section-number">4.4</span> Risk-stratification</h2>
<p>Current cardiopreventive guidelines place strong emphasis on prevention and treatment of T2D. The 2022 ADA/EASD guidelines for the management of hyperglycemia in T2D recommend, cardioprotective medication (glucagon-like peptide-1 receptor agonists [GLP-1RA] and Sodium-Glucose Transport Protein 2 inhibitors [SGLT2i]) as first-line options for individuals at high cardiovascular risk.<span class="citation" data-cites="davies2022"><sup><a href="references.html#ref-davies2022" role="doc-biblioref">66</a></sup></span> Due to their benefits in heart failure, SGLT2i are specifically recommended for patients with documented HFrEF or HFpEF. High cardiovascular risk is defined as the presence of at least two risk factors at age &gt;55 years, such as obesity, hypertension, smoking, dyslipidemia, or albuminuria.<span class="citation" data-cites="davies2022"><sup><a href="references.html#ref-davies2022" role="doc-biblioref">66</a></sup></span> However, no additional preclinical markers are recommended to identify individuals at higher CVD or HF risk or for younger individuals. Despite their increased risk of cardiovascular complications, individuals at high risk of developing diabetes remain outside structured treatment options, even though diabetes risk and cardiometabolic markers can be successfully modified through lifestyle interventions and medication such as GLP-1 analogoues.<span class="citation" data-cites="reductio2002 kahn2024"><sup><a href="references.html#ref-reductio2002" role="doc-biblioref">67</a>,<a href="references.html#ref-kahn2024" role="doc-biblioref">68</a></sup></span></p>
<p>During the progression towards and following the onset of T2D, dysglycaemia may be accompanied by early signs of cardiovascular dysfunction, such as arterial stiffness or cardiac remodeling.<span class="citation" data-cites="loehr2016 li2021"><sup><a href="references.html#ref-loehr2016" role="doc-biblioref">69</a>,<a href="references.html#ref-li2021" role="doc-biblioref">70</a></sup></span> These reflect underlying disease processes that indicate elevated CVD risk. Risk stratification, the classification of individuals by estimated risk using conventional scores such as SCORE2 or Framingham, biomarker levels, omic data including metabolomic, proteomic and genomic profiles, or preclinical indicators, can support early identification of high risk individuals.<span class="citation" data-cites="score2workinggroupandesccardiovascularriskcollaboration2021 dagostino2008 franks2023"><sup><a href="references.html#ref-score2workinggroupandesccardiovascularriskcollaboration2021" role="doc-biblioref">71</a>–<a href="references.html#ref-franks2023" role="doc-biblioref">73</a></sup></span></p>
<p>While traditional risk scores rely on established risk factors, predictive accuracy may be improved by incorporating intermediate preclinical measurements such as HRV, pulse wave velocity or intima media thickness.<span class="citation" data-cites="score2workinggroupandesccardiovascularriskcollaboration2021 dagostino2008 cardoso2023 patel2017 bodapati2017 naqvitasneemz.2014 valencia-hernández2022"><sup><a href="references.html#ref-score2workinggroupandesccardiovascularriskcollaboration2021" role="doc-biblioref">71</a>,<a href="references.html#ref-dagostino2008" role="doc-biblioref">72</a>,<a href="references.html#ref-cardoso2023" role="doc-biblioref">74</a>–<a href="references.html#ref-valencia-hernández2022" role="doc-biblioref">78</a></sup></span> However, these often require more detailed clinical assessment and may be less feasible in primary care. More extensive measures of CVD risk stratification in prediabetes and type 2 diabetes may help tailor solutions to different stages of diabetes risk, ranging from lifestyle interventions in earlier stages to pharmacological treatment in later stages.<span class="citation" data-cites="birkenfeld2024 pop-busui2022 franks2023"><sup><a href="references.html#ref-birkenfeld2024" role="doc-biblioref">12</a>,<a href="references.html#ref-pop-busui2022" role="doc-biblioref">49</a>,<a href="references.html#ref-franks2023" role="doc-biblioref">73</a></sup></span></p>
<div data-fig-cap="**Conceptual risk-stratification based on preclinical disease. **" data-fig-align="center" data-fig-width="&quot;\textwidth">
<p><img src="images/web/risk_stratification.svg" class="img-fluid"> <em>(Source: Author)</em></p>
</div>
<p>Autonomic dysfunction despite its relationship with cardiovascular complication has not been used in clinical practice in Denmark. Larger epidemiological cohort studies encompassing various stages of diabetes risk, from to prediabetes, onset of T2D, and longer term progression of T2D, serve as valuable resources for identifying risk-stratification opportunities. Epidemiological studies provide a broad representation of the target population, enabling an understanding of the relationship between autonomic dysfunction and cardiovascular complications across different levels of care: public health, primary care, and secondary care. By utilizing observational cohorts, we have the potential to determine when, along the trajectory of diabetes progression, autonomic function becomes a meaningful factor for cardiovascular risk stratification.<span class="citation" data-cites="franks2023"><sup><a href="references.html#ref-franks2023" role="doc-biblioref">73</a></sup></span></p>


<div id="refs" class="references csl-bib-body" role="list" style="display: none">
<div id="ref-tabák2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">1 </div><div class="csl-right-inline">Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. <a href="https://doi.org/10.1016/S0140-6736(12)60283-9">Prediabetes: A high-risk state for diabetes development</a>. <em>The Lancet</em> 2012; <strong>379</strong>: 2279–90.</div>
</div>
<div id="ref-bonora2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">2 </div><div class="csl-right-inline">Bonora E, DeFronzo R. Diabetes. Epidemiology, genetics, pathogenesis, diagnosis, prevention, and treatment. 2018 DOI:<a href="https://doi.org/10.1007/978-3-319-27317-4">10.1007/978-3-319-27317-4</a>.</div>
</div>
<div id="ref-worldhealthorganization2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">3 </div><div class="csl-right-inline">World Health Organization. Diagnosis and management of type 2 diabetes (HEARTS-d). Geneva, 2020.</div>
</div>
<div id="ref-americandiabetesassociationprofessionalpracticecommittee2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">4 </div><div class="csl-right-inline">American Diabetes Association Professional Practice Committee. <a href="https://doi.org/10.2337/dc22-S002">2. Classification and diagnosis of diabetes: Standards of medical care in diabetes<span></span>2022</a>. <em>Diabetes Care</em> 2021; <strong>45</strong>: S17–38.</div>
</div>
<div id="ref-colagiuri2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">5 </div><div class="csl-right-inline">Colagiuri S, Lee CMY, Wong TY, <em>et al.</em> <a href="https://doi.org/10.2337/dc10-1206">Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes</a>. <em>Diabetes Care</em> 2010; <strong>34</strong>: 145–50.</div>
</div>
<div id="ref-mokhtar2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">6 </div><div class="csl-right-inline">Mokhtar SBA, Heide FCT van der, Oyaert KAM, <em>et al.</em> <a href="https://doi.org/10.1007/s00125-023-05986-5">(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: The maastricht study</a>. <em>Diabetologia</em> 2023; <strong>66</strong>: 2030–41.</div>
</div>
<div id="ref-huang2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">7 </div><div class="csl-right-inline">Huang Y, Cai X, Qiu M, <em>et al.</em> <a href="https://doi.org/10.1007/s00125-014-3361-2">Prediabetes and the risk of cancer: A meta-analysis</a>. <em>Diabetologia</em> 2014; <strong>57</strong>: 2261–9.</div>
</div>
<div id="ref-stehouwer2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">8 </div><div class="csl-right-inline">Stehouwer CDA. <a href="https://doi.org/10.2337/dbi17-0044">Microvascular dysfunction and hyperglycemia: A vicious cycle with widespread consequences</a>. <em>Diabetes</em> 2018; <strong>67</strong>: 1729–41.</div>
</div>
<div id="ref-rooney2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">9 </div><div class="csl-right-inline">Rooney MR, Fang M, Ogurtsova K, <em>et al.</em> <a href="https://doi.org/10.2337/dc22-2376">Global prevalence of prediabetes</a>. <em>Diabetes Care</em> 2023; <strong>46</strong>: 1388–94.</div>
</div>
<div id="ref-færch2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">10 </div><div class="csl-right-inline">Færch K, Witte DR, Tabák AG, <em>et al.</em> <a href="https://doi.org/10.1016/S2213-8587(13)70008-1">Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.</a> <em>The lancet Diabetes &amp; endocrinology</em> 2013; <strong>1</strong>: 43–51.</div>
</div>
<div id="ref-ritchie2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">11 </div><div class="csl-right-inline">Ritchie RH, Abel ED. <a href="https://doi.org/10.1161/CIRCRESAHA.120.315913">Basic mechanisms of diabetic heart disease</a>. <em>Circulation Research</em> 2020; <strong>126</strong>: 1501–25.</div>
</div>
<div id="ref-birkenfeld2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">12 </div><div class="csl-right-inline">Birkenfeld AL, Franks PW, Mohan V. <a href="https://doi.org/10.1161/CIRCULATIONAHA.124.070463">Precision medicine in people at risk for diabetes and atherosclerotic cardiovascular disease: A fresh perspective on prevention</a>. <em>Circulation</em> 2024; <strong>150</strong>: 1910–2.</div>
</div>
<div id="ref-yusuf2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">13 </div><div class="csl-right-inline">Yusuf S, Joseph P, Rangarajan S, <em>et al.</em> <a href="https://doi.org/10.1016/S0140-6736(19)32008-2">Modifiable risk factors, cardiovascular disease, and mortality in 155<span></span>722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study</a>. <em>The Lancet</em> 2020; <strong>395</strong>: 795–808.</div>
</div>
<div id="ref-wood2001" class="csl-entry" role="listitem">
<div class="csl-left-margin">14 </div><div class="csl-right-inline">Wood D. <a href="https://doi.org/10.1067/mhj.2001.109951">Established and emerging cardiovascular risk factors</a>. <em>American Heart Journal</em> 2001; <strong>141</strong>: S49–57.</div>
</div>
<div id="ref-moore2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">15 </div><div class="csl-right-inline">Moore KJ. <a href="https://doi.org/10.1038/s41569-018-0144-3">Targeting inflammation in CVD: Advances and challenges</a>. <em>Nature Reviews Cardiology</em> 2019; <strong>16</strong>: 74–5.</div>
</div>
<div id="ref-fuchs2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">16 </div><div class="csl-right-inline">Fuchs FD, Whelton PK. <a href="https://doi.org/10.1161/HYPERTENSIONAHA.119.14240">High blood pressure and cardiovascular disease</a>. <em>Hypertension</em> 2020; <strong>75</strong>: 285–92.</div>
</div>
<div id="ref-mitchell2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">17 </div><div class="csl-right-inline">Mitchell GF, Powell JT. <a href="https://doi.org/10.1161/ATVBAHA.120.314208">Arteriosclerosis</a>. <em>Arteriosclerosis, Thrombosis, and Vascular Biology</em> 2020; <strong>40</strong>: 1025–7.</div>
</div>
<div id="ref-florea2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">18 </div><div class="csl-right-inline">Florea VG, Cohn JN. <a href="https://doi.org/10.1161/CIRCRESAHA.114.302589">The autonomic nervous system and heart failure</a>. <em>Circulation Research</em> 2014; <strong>114</strong>: 1815–26.</div>
</div>
<div id="ref-mancia2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">19 </div><div class="csl-right-inline">Mancia G, Grassi G. <a href="https://doi.org/10.1161/CIRCRESAHA.114.302524">The autonomic nervous system and hypertension</a>. <em>Circulation Research</em> 2014; <strong>114</strong>: 1804–14.</div>
</div>
<div id="ref-ziegler2025" class="csl-entry" role="listitem">
<div class="csl-left-margin">20 </div><div class="csl-right-inline">Ziegler KA, Engelhardt S, Carnevale D, <em>et al.</em> <a href="https://doi.org/10.1161/CIRCRESAHA.125.325580">Neural mechanisms in cardiovascular health and disease</a>. <em>Circulation Research</em> 2025; <strong>136</strong>: 1233–61.</div>
</div>
<div id="ref-wagner2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">21 </div><div class="csl-right-inline">Wagner JUG, Tombor LS, Malacarne PF, <em>et al.</em> <a href="https://doi.org/10.1126/science.ade4961">Aging impairs the neurovascular interface in the heart</a>. <em>Science</em> 2023; <strong>381</strong>: 897–906.</div>
</div>
<div id="ref-lee2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">22 </div><div class="csl-right-inline">Lee H-Y, Oh B-H. <a href="https://doi.org/10.1253/circj.CJ-10-0910">Aging and arterial stiffness</a>. <em>Circulation Journal</em> 2010; <strong>74</strong>: 2257–62.</div>
</div>
<div id="ref-lu2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">23 </div><div class="csl-right-inline">Lu Y, Kiechl SJ, Wang J, Xu Q, Kiechl S, Pechlaner R. <a href="https://doi.org/10.1016/j.ebiom.2023.104619">Global distributions of age- and sex-related arterial stiffness: systematic review and meta-analysis of 167 studies with 509,743 participants</a>. <em>EBioMedicine</em> 2023; <strong>92</strong>: 104619.</div>
</div>
<div id="ref-zhong2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">24 </div><div class="csl-right-inline">Zhong Q, Hu M-J, Cui Y-J, <em>et al.</em> <a href="https://doi.org/10.1177/0003319717742544">Carotid<span></span>femoral pulse wave velocity in the prediction of cardiovascular events and mortality: An updated systematic review and meta-analysis</a>. <em>Angiology</em> 2018; <strong>69</strong>: 617–29.</div>
</div>
<div id="ref-libby2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">25 </div><div class="csl-right-inline">Libby P. <a href="https://doi.org/10.1038/s41586-021-03392-8">The changing landscape of atherosclerosis</a>. <em>Nature</em> 2021; <strong>592</strong>: 524–33.</div>
</div>
<div id="ref-zaman" class="csl-entry" role="listitem">
<div class="csl-left-margin">26 </div><div class="csl-right-inline">Zaman S, Wasfy JH, Kapil V, <em>et al.</em> The lancet commission on rethinking coronary artery disease: Moving from ischaemia to atheroma. <em>The Lancet</em> DOI:<a href="https://doi.org/10.1016/S0140-6736(25)00055-8">10.1016/S0140-6736(25)00055-8</a>.</div>
</div>
<div id="ref-kawai2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">27 </div><div class="csl-right-inline">Kawai K, Kawakami R, Finn AV, Virmani R. <a href="https://doi.org/10.1161/ATVBAHA.124.319396">Differences in stable and unstable atherosclerotic plaque</a>. <em>Arteriosclerosis, Thrombosis, and Vascular Biology</em> 2024; <strong>44</strong>: 1474–84.</div>
</div>
<div id="ref-alasady2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">28 </div><div class="csl-right-inline">Alasady M, Shipp NJ, Brooks AG, <em>et al.</em> <a href="https://doi.org/10.1161/CIRCEP.113.000163">Myocardial infarction and atrial fibrillation</a>. <em>Circulation: Arrhythmia and Electrophysiology</em> 2013; <strong>6</strong>: 738–45.</div>
</div>
<div id="ref-elgendy2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">29 </div><div class="csl-right-inline">Elgendy IY, Mahtta D, Pepine CJ. <a href="https://doi.org/10.1161/CIRCRESAHA.118.313568">Medical therapy for heart failure caused by ischemic heart disease</a>. <em>Circulation Research</em> 2019; <strong>124</strong>: 1520–35.</div>
</div>
<div id="ref-thygesen2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">30 </div><div class="csl-right-inline">Thygesen K, Alpert JS, Jaffe AS, <em>et al.</em> <a href="https://doi.org/10.1161/CIR.0000000000000617">Fourth universal definition of myocardial infarction (2018)</a>. <em>Circulation</em> 2018; <strong>138</strong>: e618–51.</div>
</div>
<div id="ref-cherla2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">31 </div><div class="csl-right-inline">Cherla A, Kyriopoulos I, Pearcy P, <em>et al.</em> Trends in avoidable mortality from cardiovascular diseases in the european union, 1995<span></span>2020: A retrospective secondary data analysis. <em>The Lancet Regional Health <span></span> Europe</em> 2024; <strong>47</strong>. DOI:<a href="https://doi.org/10.1016/j.lanepe.2024.101079">10.1016/j.lanepe.2024.101079</a>.</div>
</div>
<div id="ref-bilano2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">32 </div><div class="csl-right-inline">Bilano V, Gilmour S, Moffiet T, <em>et al.</em> <a href="https://doi.org/10.1016/S0140-6736(15)60264-1">Global trends and projections for tobacco use, 1990<span></span>2025: An analysis of smoking indicators from the WHO comprehensive information systems for tobacco control</a>. <em>The Lancet</em> 2015; <strong>385</strong>: 966–76.</div>
</div>
<div id="ref-ockene1997" class="csl-entry" role="listitem">
<div class="csl-left-margin">33 </div><div class="csl-right-inline">Ockene IS, Miller NH. <a href="https://doi.org/10.1161/01.CIR.96.9.3243">Cigarette smoking, cardiovascular disease, and stroke</a>. <em>Circulation</em> 1997; <strong>96</strong>: 3243–7.</div>
</div>
<div id="ref-wallentin2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">34 </div><div class="csl-right-inline">Wallentin L, Kristensen SD, Anderson JL, <em>et al.</em> <a href="https://doi.org/10.1016/j.ahj.2014.07.006">How can we optimize the processes of care for acute coronary syndromes to improve outcomes?</a> <em>American Heart Journal</em> 2014; <strong>168</strong>: 622–631.e2.</div>
</div>
<div id="ref-shah2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">35 </div><div class="csl-right-inline">Shah AD, Langenberg C, Rapsomaniki E, <em>et al.</em> <a href="https://doi.org/10.1016/S2213-8587(14)70219-0">Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1·9 million people</a>. <em>The Lancet Diabetes &amp; Endocrinology</em> 2015; <strong>3</strong>: 105–13.</div>
</div>
<div id="ref-glynn2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">36 </div><div class="csl-right-inline">Glynn L, Lind M, Andersson T, Eliasson B, Hofmann R, Nyström T. <a href="https://doi.org/10.1161/JAHA.123.034741">Trends in survival after first myocardial infarction in people with diabetes</a>. <em>Journal of the American Heart Association</em> 2024; <strong>13</strong>: e034741.</div>
</div>
<div id="ref-greggedwardw.a" class="csl-entry" role="listitem">
<div class="csl-left-margin">37 </div><div class="csl-right-inline">Gregg Edward W., Li Yanfeng, Wang Jing, <em>et al.</em> <a href="https://doi.org/10.1056/NEJMoa1310799">Changes in diabetes-related complications in the united states, 1990<span></span>2010</a>. <em>New England Journal of Medicine</em>; <strong>370</strong>: 1514–23.</div>
</div>
<div id="ref-campbell2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">38 </div><div class="csl-right-inline">Campbell BCV, De Silva DA, Macleod MR, <em>et al.</em> <a href="https://doi.org/10.1038/s41572-019-0118-8">Ischaemic stroke</a>. <em>Nature Reviews Disease Primers</em> 2019; <strong>5</strong>: 70.</div>
</div>
<div id="ref-magid-bernstein2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">39 </div><div class="csl-right-inline">Magid-Bernstein J, Girard R, Polster S, <em>et al.</em> <a href="https://doi.org/10.1161/CIRCRESAHA.121.319949">Cerebral hemorrhage: Pathophysiology, treatment, and future directions</a>. <em>Circulation Research</em> 2022; <strong>130</strong>: 1204–29.</div>
</div>
<div id="ref-donnan2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">40 </div><div class="csl-right-inline">Donnan GA, Fisher M, Macleod M, Davis SM. <a href="https://doi.org/10.1016/S0140-6736(08)60694-7">Stroke</a>. <em>The Lancet</em> 2008; <strong>371</strong>: 1612–23.</div>
</div>
<div id="ref-vos2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">41 </div><div class="csl-right-inline">Vos T, Lim SS, Abbafati C, <em>et al.</em> <a href="https://doi.org/10.1016/S0140-6736(20)30925-9">Global burden of 369 diseases and injuries in 204 countries and territories, 1990<span></span>2019: A systematic analysis for the global burden of disease study 2019</a>. <em>The Lancet</em> 2020; <strong>396</strong>: 1204–22.</div>
</div>
<div id="ref-li2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">42 </div><div class="csl-right-inline">Li X, Kong X, Yang C, <em>et al.</em> Global, regional, and national burden of ischemic stroke, 1990<span></span>2021: An analysis of data from the global burden of disease study 2021. <em>eClinicalMedicine</em> 2024; <strong>75</strong>. DOI:<a href="https://doi.org/10.1016/j.eclinm.2024.102758">10.1016/j.eclinm.2024.102758</a>.</div>
</div>
<div id="ref-lee2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">43 </div><div class="csl-right-inline">Lee M, Saver JL, Hong K-S, Song S, Chang K-H, Ovbiagele B. <a href="https://doi.org/10.1136/bmj.e3564">Effect of pre-diabetes on future risk of stroke: Meta-analysis</a>. <em>BMJ : British Medical Journal</em> 2012; <strong>344</strong>: e3564.</div>
</div>
<div id="ref-barr2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">44 </div><div class="csl-right-inline">Barr ELM, Zimmet PZ, Welborn TA, <em>et al.</em> <a href="https://doi.org/10.1161/CIRCULATIONAHA.106.685628">Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance</a>. <em>Circulation</em> 2007; <strong>116</strong>: 151–7.</div>
</div>
<div id="ref-khan2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">45 </div><div class="csl-right-inline">Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. <a href="https://doi.org/10.1038/s41569-024-01046-6">Global epidemiology of heart failure</a>. <em>Nature Reviews Cardiology</em> 2024; <strong>21</strong>: 717–34.</div>
</div>
<div id="ref-heidenreich2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">46 </div><div class="csl-right-inline">Heidenreich PA, Bozkurt B, Aguilar D, <em>et al.</em> <a href="https://doi.org/10.1161/CIR.0000000000001063">2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines</a>. <em>Circulation</em> 2022; <strong>145</strong>: e895–1032.</div>
</div>
<div id="ref-campbell2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">47 </div><div class="csl-right-inline">Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. <a href="https://doi.org/10.1016/S0140-6736(23)02756-3">Heart failure with preserved ejection fraction: everything the clinician needs to know.</a> <em>Lancet (London, England)</em> 2024; <strong>403</strong>: 1083–92.</div>
</div>
<div id="ref-normand2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">48 </div><div class="csl-right-inline">Normand C, Kaye DM, Povsic TJ, Dickstein K. <a href="https://doi.org/10.1016/S0140-6736(18)32216-5">Beyond pharmacological treatment: An insight into therapies that target specific aspects of heart failure pathophysiology</a>. <em>The Lancet</em> 2019; <strong>393</strong>: 1045–55.</div>
</div>
<div id="ref-pop-busui2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">49 </div><div class="csl-right-inline">Pop-Busui R, Januzzi JL, Bruemmer D, <em>et al.</em> <a href="https://doi.org/10.2337/dci22-0014">Heart failure: An underappreciated complication of diabetes. A consensus report of the american diabetes association</a>. <em>Diabetes Care</em> 2022; <strong>45</strong>: 1670–90.</div>
</div>
<div id="ref-schlaich2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">50 </div><div class="csl-right-inline">Schlaich M, Straznicky N, Lambert E, Lambert G. <a href="https://doi.org/10.1016/s2213-8587(14)70033-6">Metabolic syndrome: a sympathetic disease?</a> <em>Lancet Diabetes Endocrinol</em> 2015; <strong>3</strong>: 148–57.</div>
</div>
<div id="ref-rinaldi2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">51 </div><div class="csl-right-inline">Rinaldi E, Heide FCT van der, Bonora E, <em>et al.</em> <a href="https://doi.org/10.1186/s12933-023-01837-0">Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo<span></span>the maastricht study</a>. <em>Cardiovascular Diabetology</em> 2023; <strong>22</strong>: 105.</div>
</div>
<div id="ref-eleftheriadou2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">52 </div><div class="csl-right-inline">Eleftheriadou A, Spallone V, Tahrani AA, Alam U. <a href="https://doi.org/10.1007/s00125-024-06242-0">Cardiovascular autonomic neuropathy in diabetes: An update with a focus on management</a>. <em>Diabetologia</em> 2024; <strong>67</strong>: 2611–25.</div>
</div>
<div id="ref-mahinchowdhury2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">53 </div><div class="csl-right-inline">Mahin Chowdhury, Sarah Nevitt, Aikaterini Eleftheriadou, <em>et al.</em> <a href="https://doi.org/10.1136/bmjdrc-2021-002480">Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: A meta-analysis</a>. <em>BMJ Open Diabetes Research &amp; Care</em> 2021; <strong>9</strong>: e002480.</div>
</div>
<div id="ref-tang2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">54 </div><div class="csl-right-inline">Tang Y, Ang L, Jaiswal M, <em>et al.</em> <a href="https://doi.org/10.2337/db23-0247">Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: Findings from the PERL and ACCORD cohorts</a>. <em>Diabetes</em> 2023; <strong>73</strong>: 751–62.</div>
</div>
<div id="ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" class="csl-entry" role="listitem">
<div class="csl-left-margin">55 </div><div class="csl-right-inline">Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. <a href="https://doi.org/doi:10.1161/01.CIR.93.5.1043">Heart rate variability</a>. <em>Circulation</em> 1996; <strong>93</strong>: 1043–65.</div>
</div>
<div id="ref-natarajan2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">56 </div><div class="csl-right-inline">Natarajan A, Pantelopoulos A, Emir-Farinas H, Natarajan P. <a href="https://doi.org/10.1016/S2589-7500(20)30246-6">Heart rate variability with photoplethysmography in 8 million individuals: A cross-sectional study</a>. <em>The Lancet Digital Health</em> 2020; <strong>2</strong>: e650–7.</div>
</div>
<div id="ref-hillebrand2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">57 </div><div class="csl-right-inline">Hillebrand S, Gast KB, Mutsert R de, <em>et al.</em> <a href="https://doi.org/10.1093/europace/eus341">Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: Meta-analysis and dose<span></span>response meta-regression</a>. <em>EP Europace</em> 2013; <strong>15</strong>: 742–9.</div>
</div>
<div id="ref-immanuel2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">58 </div><div class="csl-right-inline">Immanuel S, Teferra MN, Baumert M, Bidargaddi N. <a href="https://doi.org/10.1159/000530376">Heart rate variability for evaluating psychological stress changes in healthy adults: A scoping review</a>. <em>Neuropsychobiology</em> 2023; <strong>82</strong>: 187–202.</div>
</div>
<div id="ref-dong2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">59 </div><div class="csl-right-inline">Dong J-G. <a href="https://doi.org/10.3892/etm.2016.3104">The role of heart rate variability in sports physiology (review)</a>. <em>Experimental and Therapeutic Medicine</em> 2016; <strong>11</strong>: 1531–6.</div>
</div>
<div id="ref-singh1996" class="csl-entry" role="listitem">
<div class="csl-left-margin">60 </div><div class="csl-right-inline">Singh N, Mironov D, Armstrong PW, Ross AM, Langer A. <a href="https://doi.org/10.1161/01.CIR.93.7.1388">Heart rate variability assessment early after acute myocardial infarction</a>. <em>Circulation</em> 1996; <strong>93</strong>: 1388–95.</div>
</div>
<div id="ref-huggett2003" class="csl-entry" role="listitem">
<div class="csl-left-margin">61 </div><div class="csl-right-inline">Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DASG. <a href="https://doi.org/10.1161/01.CIR.0000103123.66264.FE">Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension</a>. <em>Circulation</em> 2003; <strong>108</strong>: 3097–101.</div>
</div>
<div id="ref-cseh2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">62 </div><div class="csl-right-inline">Cseh D, Climie RE, Offredo L, <em>et al.</em> <a href="https://doi.org/10.1161/ATVBAHA.120.314102">Type 2 diabetes mellitus is independently associated with decreased neural baroreflex sensitivity</a>. <em>Arteriosclerosis, Thrombosis, and Vascular Biology</em> 2020; <strong>40</strong>: 1420–8.</div>
</div>
<div id="ref-coopmans2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">63 </div><div class="csl-right-inline">Coopmans C, Zhou TL, Henry RMA, <em>et al.</em> <a href="https://doi.org/10.2337/dc19-2367">Both prediabetes and type 2 diabetes are associated with lower heart rate variability: The maastricht study</a>. <em>Diabetes Care</em> 2020; <strong>43</strong>: 1126–33.</div>
</div>
<div id="ref-hansen2025" class="csl-entry" role="listitem">
<div class="csl-left-margin">64 </div><div class="csl-right-inline">Hansen CS, Christensen MMB, Vistisen D, <em>et al.</em> <a href="https://doi.org/10.1007/s10286-024-01069-6">Normative data on measures of cardiovascular autonomic neuropathy and the effect of pretest conditions in a large danish non-diabetic CVD-free population from the lolland-falster health study</a>. <em>Clinical Autonomic Research</em> 2025; <strong>35</strong>: 101–13.</div>
</div>
<div id="ref-davis2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">65 </div><div class="csl-right-inline">Davis TME, Tan E, Davis WA. <a href="https://doi.org/10.1186/s12933-024-02185-3">Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: The fremantle diabetes study phase II</a>. <em>Cardiovascular Diabetology</em> 2024; <strong>23</strong>: 102.</div>
</div>
<div id="ref-davies2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">66 </div><div class="csl-right-inline">Davies MJ, Aroda VR, Collins BS, <em>et al.</em> <a href="https://doi.org/10.2337/dci22-0034">Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)</a>. <em>Diabetes Care</em> 2022; <strong>45</strong>: 2753–86.</div>
</div>
<div id="ref-reductio2002" class="csl-entry" role="listitem">
<div class="csl-left-margin">67 </div><div class="csl-right-inline"><a href="https://doi.org/10.1056/NEJMoa012512">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</a>. <em>New England Journal of Medicine</em> 2002; <strong>346</strong>: 393–403.</div>
</div>
<div id="ref-kahn2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">68 </div><div class="csl-right-inline">Kahn SE, Deanfield JE, Jeppesen OK, <em>et al.</em> <a href="https://doi.org/10.2337/dc24-0491">Effect of semaglutide on regression and progression of glycemia in people with overweight or obesity but without diabetes in the SELECT trial</a>. <em>Diabetes Care</em> 2024; <strong>47</strong>: 1350–9.</div>
</div>
<div id="ref-loehr2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">69 </div><div class="csl-right-inline">Loehr LR, Meyer ML, Poon AK, <em>et al.</em> <a href="https://doi.org/10.1093/ajh/hpw036">Prediabetes and diabetes are associated with arterial stiffness in older adults: The ARIC study</a>. <em>American Journal of Hypertension</em> 2016; <strong>29</strong>: 1038–45.</div>
</div>
<div id="ref-li2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">70 </div><div class="csl-right-inline">Li T, Li G, Guo X, Li Z, Yang J, Sun Y. <a href="https://doi.org/10.1016/j.jdiacomp.2020.107771">The influence of diabetes and prediabetes on left heart remodeling: A population-based study</a>. <em>Journal of Diabetes and its Complications</em> 2021; <strong>35</strong>: 107771.</div>
</div>
<div id="ref-score2workinggroupandesccardiovascularriskcollaboration2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">71 </div><div class="csl-right-inline">group S working, ESC Cardiovascular risk collaboration. <a href="https://doi.org/10.1093/eurheartj/ehab309">SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in europe</a>. <em>European Heart Journal</em> 2021; <strong>42</strong>: 2439–54.</div>
</div>
<div id="ref-dagostino2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">72 </div><div class="csl-right-inline">D’Agostino RB, Vasan RS, Pencina MJ, <em>et al.</em> <a href="https://doi.org/10.1161/CIRCULATIONAHA.107.699579">General cardiovascular risk profile for use in primary care</a>. <em>Circulation</em> 2008; <strong>117</strong>: 743–53.</div>
</div>
<div id="ref-franks2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">73 </div><div class="csl-right-inline">Franks PW, Cefalu WT, Dennis J, <em>et al.</em> <a href="https://doi.org/10.1016/s2213-8587(23)00165-1">Precision medicine for cardiometabolic disease: a framework for clinical translation</a>. <em>Lancet Diabetes Endocrinol</em> 2023; <strong>11</strong>: 822–35.</div>
</div>
<div id="ref-cardoso2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">74 </div><div class="csl-right-inline">Cardoso CRL, Oliveira VAG de, Leite NC, Salles GF. <a href="https://doi.org/10.1016/j.diabres.2022.110232">Prognostic importance of cardiovascular autonomic neuropathy on cardiovascular and mortality outcomes in individuals with type 2 diabetes: The rio de janeiro type 2 diabetes cohort</a>. <em>Diabetes Research and Clinical Practice</em> 2023; <strong>196</strong>: 110232.</div>
</div>
<div id="ref-patel2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">75 </div><div class="csl-right-inline">Patel VN, Pierce BR, Bodapati RK, Brown DL, Ives DG, Stein PK. <a href="https://doi.org/10.1016/j.jchf.2016.12.015">Association of holter-derived heart rate variability parameters with the development of congestive heart failure in the cardiovascular health study</a>. <em>JACC: Heart Failure</em> 2017; <strong>5</strong>: 423–31.</div>
</div>
<div id="ref-bodapati2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">76 </div><div class="csl-right-inline">Bodapati RK, Kizer JR, Kop WJ, Kamel H, Stein PK. Addition of 24-Hour Heart Rate Variability Parameters to the Cardiovascular Health Study Stroke Risk Score and Prediction of Incident Stroke: The Cardiovascular Health Study. <em>Journal of the American Heart Association</em> 2017; <strong>6</strong>. DOI:<a href="https://doi.org/10.1161/JAHA.116.004305">10.1161/JAHA.116.004305</a>.</div>
</div>
<div id="ref-naqvitasneemz.2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">77 </div><div class="csl-right-inline">Naqvi Tasneem Z., Lee Ming-Sum. <a href="https://doi.org/10.1016/j.jcmg.2013.11.014">Carotid intima-media thickness and plaque&nbsp;in cardiovascular risk assessment</a>. <em>JACC: Cardiovascular Imaging</em> 2014; <strong>7</strong>: 1025–38.</div>
</div>
<div id="ref-valencia-hernández2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">78 </div><div class="csl-right-inline">Valencia-Hernández CA, Lindbohm JV, Shipley MJ, <em>et al.</em> <a href="https://doi.org/10.1161/HYPERTENSIONAHA.121.17589">Aortic pulse wave velocity as adjunct risk marker for assessing cardiovascular disease risk: Prospective study</a>. <em>Hypertension</em> 2022; <strong>79</strong>: 836–43.</div>
</div>
</div>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./1-introduction.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Introduction</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./3-aim_hypothesis.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Aim and hypothesis</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>